Insider trades

Cyrus Harmon, Director of Olema Pharmaceuticals OLMA, has filed 0 purchases and 39 sales on the open market. Over the past 12 months that comes to a net sale of $452.6K. The latest trade was on 06/18.

Cyrus Harmon

Director
First filing
23/02/02
Trades
45 trades
Buys / sales
0 / 39
12-month net buying
−$452.6K
Last trade
06/18

Trading activity

Transactions

Trade type
Open-market sale01/2001/2110,000 sh$26.88$268,800−1.4%
Open-market sale01/1401/163,489 sh$29.12$101,599.68−0.5%
Open-market sale25/12/2225/12/292,881 sh$28.53$82,194.93−0.4%
OLMA
Open-market sale25/09/16–25/09/1825/09/1825,000 sh4 trades$8.19avg.$204,840.64No record
OLMA
Open-market sale24/12/10–24/12/1124/12/1116,393 sh3 trades$9.03avg.$147,955.81−2.1%
OLMA
Open-market sale10b5-1 plan24/07/29–24/07/3024/07/315,000 sh2 trades$15.57avg.$77,871.98−0.7%
Open-market sale10b5-1 plan24/07/1124/07/125,000 sh$12.26$61,300−0.7%
Open-market sale10b5-1 plan24/06/2824/07/0220,000 sh$10.77$215,400−2.6%
OLMA
Open-market sale10b5-1 plan24/05/31–24/06/0424/06/0425,000 sh3 trades$10.30avg.$257,450−3.1%
Open-market sale10b5-1 plan24/05/0624/05/075,000 sh$10.92$54,600−0.6%
Open-market sale10b5-1 plan24/04/3024/05/0215,000 sh$9.51$142,650−1.8%
Open-market sale10b5-1 plan24/03/2824/03/2920,000 sh$10.97$219,400−2.4%
OLMA
Open-market sale10b5-1 plan24/02/2924/03/0425,000 sh2 trades$12.41avg.$310,309−2.9%
OLMA
Open-market sale10b5-1 plan24/01/31–24/02/0124/02/0230,000 sh2 trades$12.79avg.$383,550−3.3%
OLMA
Open-market sale23/12/2924/01/0225,000 sh2 trades$13.38avg.$334,500−2.7%
Open-market sale10b5-1 plan23/11/3023/12/0125,000 sh$12.57$314,250−2.6%
OLMA
Open-market sale23/11/21–23/11/2223/11/228,181 sh2 trades$14.39avg.$117,740.22−0.9%
OLMA
Open-market sale10b5-1 plan23/10/31–23/11/0223/11/0230,000 sh2 trades$12.65avg.$379,450−3.1%
Open-market sale10b5-1 plan23/09/2923/10/0325,000 sh$12.41$310,250−2.5%
OLMA
Open-market sale10b5-1 plan · Amendment23/08/16–23/09/0523/09/0540,000 sh3 trades$10.22avg.$408,700−3.9%